Our previous study on mouse hematologic neoplasm cells indicated that a blockade of ICOS/ICOSL pathways in tumor cells led to the downregulation of IL-4 and IL-10, both of which have anti-inflammatory effects (Wang et al., 2012). The gene discussed is IL10; the disease is hematopoietic and lymphoid system neoplasm.